Nordics & clinical trials: 3 reasons why this region is so important

1st January, 1970

Nordics & clinical trials: 3 reasons why this region is so important

The Nordics biotech industry has been growing for some time to a point where we see a distinct hub as separate to Europe when it comes to clinical trials. This article aims to help you to understand why the Nordic region is the place to discuss clinical trials.

Clinical trials activity has bloomed in many Nordic countries but dropped in some too, so why is this region so important when it comes to clinical trials?

1.       Innovation in clinical trials

Innovation is a really important when it comes to clinical trials, and Nordic region happens to be home to some of the world’s most innovative pharma and biotech companies. In addition, countries in this region are more open to challenges and are keen to debate new ideas in clinical trials strategies.

2.       Leading pharma companies

Pharma companies are flourishing in the Scandinavian area, birthplace of many regional leaders such as Novo Nordisk, Pfizer or AstraZeneca. Denmark has the highest number of biotech patents filed in the world and Nordic governments are investing heavily in clinical trials research and development.

3.       Pharma hubs

Copenhagen is a biotech hub for Nordics and has a very accessible connection to Malmö – Sweden’s key pharma hub. Also, let’s not forget that Copenhagen is one of the largest science clusters in Europe, making technological innovation and advancement in clinical trials more efficient.

This October Outsourcing in Clinical Trials Nordics comes back to Copenhagen for a 5th time! It will offer an exclusive opportunity to network with industry professional within the region and form meaningful partnerships now and in the future. You will also be able to listen to success and failure case studies, meet suppliers and have detailed discussions to source solutions to your own supply chain issues.

In the morning of day one, we will talk about the ways to boost clinical trial activity in the Nordics even further. We will be joined by NEXT Partnership and Danish Medicines Agency for a keynote session on how to make Denmark more attractive country for clinical trials, followed by debate on how to boost clinical trials activity in the Nordics through collaboration and positioning.

Visit for more information on or email us at for more information on how to join us in Copenhagen. Improving you clinical trials strategy has never been easier!


Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the

If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:

Paul Adams
+44 (0)20 7936 6948

Speaker opportunities

We identify and invite individuals we believe to be the best speakers in the market, if you think you can make a difference to the quality of our events please contact:

Chloe Roberts
T: +44 (0)207 936 6822